Toxic Hepatitis Following Ketoconazole Treatment
Ketoconazole, a new broad-spectrum oral antifungal agent, has proved most useful in the treatment of superficial and systemic fungal infections. Chronic conditions like mucocutaneous candidiasis can be treated with but few side effects. An increasing number of cases have, however, been noted of seve...
Gespeichert in:
Veröffentlicht in: | Scandinavian journal of infectious diseases 1984, Vol.16 (1), p.123-125 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 125 |
---|---|
container_issue | 1 |
container_start_page | 123 |
container_title | Scandinavian journal of infectious diseases |
container_volume | 16 |
creator | SVEDHEM, A |
description | Ketoconazole, a new broad-spectrum oral antifungal agent, has proved most useful in the treatment of superficial and systemic fungal infections. Chronic conditions like mucocutaneous candidiasis can be treated with but few side effects. An increasing number of cases have, however, been noted of severe toxic hepatitis, following ketoconazole treatment. A new case (a 61-yr-old woman treated for onychomycosis) is reported here. |
doi_str_mv | 10.3109/00365548409068418 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_8959432</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14279505</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-3d16ec0852bd0ce0ea6d2dae8fc65e6f6ef251231fd319c5b69c03501397a7d13</originalsourceid><addsrcrecordid>eNp9kEFLAzEUhIMotVZ_gAehB_G2-rLZpBv0IsVaseClnpc0-9ZuyW5qkqXWX--W1oIIPb3DfDPMG0IuKdwyCvIOgAnOkzQBCSJNaHpEulRwGlGZwjHpbvRoA5ySM-8XAJAIBh3SESwGxtMugan9KnV_jEsVylD6_sgaY1dl_dF_xWC1rdW3NdifOlShwjqck5NCGY8Xu9sj76On6XAcTd6eX4aPk0gngoaI5VSghpTHsxw0AiqRx7nCtNCCoygEFjGnMaNFzqjUfCakbhsBZXKgBjllPXKzzV06-9mgD1lVeo3GqBpt4zOaxAPJgbcg3YLaWe8dFtnSlZVy64xCtlkp-7dS67nahTezCvO9YzdLq1_vdOW1MoVTtS79HksllwmLW-xhi5V1YV2lVtaZPAtqbaz79bBDLe7_2OeoTJhr5TBb2MbV7bwHfvgBmSWTZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14279505</pqid></control><display><type>article</type><title>Toxic Hepatitis Following Ketoconazole Treatment</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Taylor & Francis Journals Complete</source><creator>SVEDHEM, A</creator><creatorcontrib>SVEDHEM, A</creatorcontrib><description>Ketoconazole, a new broad-spectrum oral antifungal agent, has proved most useful in the treatment of superficial and systemic fungal infections. Chronic conditions like mucocutaneous candidiasis can be treated with but few side effects. An increasing number of cases have, however, been noted of severe toxic hepatitis, following ketoconazole treatment. A new case (a 61-yr-old woman treated for onychomycosis) is reported here.</description><identifier>ISSN: 0036-5548</identifier><identifier>EISSN: 1651-1980</identifier><identifier>DOI: 10.3109/00365548409068418</identifier><identifier>PMID: 6320358</identifier><identifier>CODEN: SJIDB7</identifier><language>eng</language><publisher>Basingstoke: Informa UK Ltd</publisher><subject>Biological and medical sciences ; Candidiasis - drug therapy ; Chemical and Drug Induced Liver Injury - etiology ; Drug toxicity and drugs side effects treatment ; Female ; Humans ; Ketoconazole - adverse effects ; Ketoconazole - therapeutic use ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Toxicity: digestive system</subject><ispartof>Scandinavian journal of infectious diseases, 1984, Vol.16 (1), p.123-125</ispartof><rights>1984 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1984</rights><rights>1985 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-3d16ec0852bd0ce0ea6d2dae8fc65e6f6ef251231fd319c5b69c03501397a7d13</citedby><cites>FETCH-LOGICAL-c461t-3d16ec0852bd0ce0ea6d2dae8fc65e6f6ef251231fd319c5b69c03501397a7d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/00365548409068418$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/00365548409068418$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=8959432$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6320358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SVEDHEM, A</creatorcontrib><title>Toxic Hepatitis Following Ketoconazole Treatment</title><title>Scandinavian journal of infectious diseases</title><addtitle>Scand J Infect Dis</addtitle><description>Ketoconazole, a new broad-spectrum oral antifungal agent, has proved most useful in the treatment of superficial and systemic fungal infections. Chronic conditions like mucocutaneous candidiasis can be treated with but few side effects. An increasing number of cases have, however, been noted of severe toxic hepatitis, following ketoconazole treatment. A new case (a 61-yr-old woman treated for onychomycosis) is reported here.</description><subject>Biological and medical sciences</subject><subject>Candidiasis - drug therapy</subject><subject>Chemical and Drug Induced Liver Injury - etiology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Ketoconazole - adverse effects</subject><subject>Ketoconazole - therapeutic use</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxicity: digestive system</subject><issn>0036-5548</issn><issn>1651-1980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFLAzEUhIMotVZ_gAehB_G2-rLZpBv0IsVaseClnpc0-9ZuyW5qkqXWX--W1oIIPb3DfDPMG0IuKdwyCvIOgAnOkzQBCSJNaHpEulRwGlGZwjHpbvRoA5ySM-8XAJAIBh3SESwGxtMugan9KnV_jEsVylD6_sgaY1dl_dF_xWC1rdW3NdifOlShwjqck5NCGY8Xu9sj76On6XAcTd6eX4aPk0gngoaI5VSghpTHsxw0AiqRx7nCtNCCoygEFjGnMaNFzqjUfCakbhsBZXKgBjllPXKzzV06-9mgD1lVeo3GqBpt4zOaxAPJgbcg3YLaWe8dFtnSlZVy64xCtlkp-7dS67nahTezCvO9YzdLq1_vdOW1MoVTtS79HksllwmLW-xhi5V1YV2lVtaZPAtqbaz79bBDLe7_2OeoTJhr5TBb2MbV7bwHfvgBmSWTZQ</recordid><startdate>1984</startdate><enddate>1984</enddate><creator>SVEDHEM, A</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>1984</creationdate><title>Toxic Hepatitis Following Ketoconazole Treatment</title><author>SVEDHEM, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-3d16ec0852bd0ce0ea6d2dae8fc65e6f6ef251231fd319c5b69c03501397a7d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Biological and medical sciences</topic><topic>Candidiasis - drug therapy</topic><topic>Chemical and Drug Induced Liver Injury - etiology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Ketoconazole - adverse effects</topic><topic>Ketoconazole - therapeutic use</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxicity: digestive system</topic><toplevel>online_resources</toplevel><creatorcontrib>SVEDHEM, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Scandinavian journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SVEDHEM, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxic Hepatitis Following Ketoconazole Treatment</atitle><jtitle>Scandinavian journal of infectious diseases</jtitle><addtitle>Scand J Infect Dis</addtitle><date>1984</date><risdate>1984</risdate><volume>16</volume><issue>1</issue><spage>123</spage><epage>125</epage><pages>123-125</pages><issn>0036-5548</issn><eissn>1651-1980</eissn><coden>SJIDB7</coden><abstract>Ketoconazole, a new broad-spectrum oral antifungal agent, has proved most useful in the treatment of superficial and systemic fungal infections. Chronic conditions like mucocutaneous candidiasis can be treated with but few side effects. An increasing number of cases have, however, been noted of severe toxic hepatitis, following ketoconazole treatment. A new case (a 61-yr-old woman treated for onychomycosis) is reported here.</abstract><cop>Basingstoke</cop><pub>Informa UK Ltd</pub><pmid>6320358</pmid><doi>10.3109/00365548409068418</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0036-5548 |
ispartof | Scandinavian journal of infectious diseases, 1984, Vol.16 (1), p.123-125 |
issn | 0036-5548 1651-1980 |
language | eng |
recordid | cdi_pascalfrancis_primary_8959432 |
source | MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete |
subjects | Biological and medical sciences Candidiasis - drug therapy Chemical and Drug Induced Liver Injury - etiology Drug toxicity and drugs side effects treatment Female Humans Ketoconazole - adverse effects Ketoconazole - therapeutic use Medical sciences Middle Aged Pharmacology. Drug treatments Toxicity: digestive system |
title | Toxic Hepatitis Following Ketoconazole Treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A04%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxic%20Hepatitis%20Following%20Ketoconazole%20Treatment&rft.jtitle=Scandinavian%20journal%20of%20infectious%20diseases&rft.au=SVEDHEM,%20A&rft.date=1984&rft.volume=16&rft.issue=1&rft.spage=123&rft.epage=125&rft.pages=123-125&rft.issn=0036-5548&rft.eissn=1651-1980&rft.coden=SJIDB7&rft_id=info:doi/10.3109/00365548409068418&rft_dat=%3Cproquest_pasca%3E14279505%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14279505&rft_id=info:pmid/6320358&rfr_iscdi=true |